| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.38 | 2e-08 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.35 | 2e-07 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.32 | 1e-06 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-06 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-06 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.26 | 3e-06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.24 | 2e-05 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.17 | 4e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.15 | 7e-05 |